DENTSPLY SIRONA

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic and orthodontic dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Dentsply Sirona (XRAY) exceeds Q4 expectations, focuses on innovation

Dentsply Sirona (XRAY) reported strong financial performance in Q4 2022, with a strategic focus on digitalization and innovation. Despite challenges in organic sales and supply chain constraints, the company aims for margin improvement and growth opportunities through investments and pricing strategies. Restructuring efforts and acquisitions are set to drive profitability and market share gains.

Dentsply Sirona reports robust Q1 growth, eyes digital innovation

Dentsply Sirona's strong Q1 performance driven by Consumables and Aligners segments.
Challenges include mixed regional performance and cautious outlook on equipment demand.
Opportunities lie in digitalization, DSO partnerships, and growth in China and EPS targets.
Overall, a positive outlook with strategic focus on innovation and customer experience.

Dentsply Sirona exceeds Q2 expectations, eyes growth amid challenges

Dentsply Sirona reported strong financial performance in Q2 2023, exceeding expectations and raising full-year outlook across key financial metrics.
The company's strategic focus on growth, profitability, and digitalization, coupled with investments in key regions and product innovation, positions it for sustained success.
While facing challenges in certain markets and operational areas, Dentsply Sirona remains optimistic about opportunities for growth, innovation, and value creation in the dental industry.
Overall, Dentsply Sirona's performance highlights operational strengths, market positioning, and a forward-looking approach to driving shareholder value and market expansion.

DENTSPLY SIRONA reports mixed Q3 results, focuses on innovation and growth

DENTSPLY SIRONA's Q3 performance showed mixed results with challenges in certain markets but strength in key segments like CAD/CAM and Aligners.
The company is focused on driving value through innovation, maintaining a commitment to long-term plans, and navigating external challenges with confidence.
Despite headwinds, DENTSPLY SIRONA remains within guidance range for the year, with a strategic focus on volume growth and market expansion opportunities.

DENTSPLY SIRONA anticipates double-digit EPS growth in 2024

DENTSPLY SIRONA's Q4 2023 performance showed growth in key segments, with strategic initiatives set for 2024 as an inflection year for double-digit EPS growth.
The company is focusing on innovation, SKU optimization, and operational efficiency to drive profitability and revenue growth.
Challenges lie in certain segments and the need for organic growth normalization by 2025, but opportunities exist in new product launches and margin expansion.
Overall, DENTSPLY SIRONA is poised for accelerated profitable growth, with 2024 expected to be a pivotal year for improved performance.

DENTSPLY SIRONA reports mixed Q1 performance amidst innovation focus

DENTSPLY SIRONA navigated challenges in Q1 with a focus on innovation, sustainability, and strategic updates. While facing headwinds in certain segments and markets, the company aims to capitalize on growth opportunities through product launches and strategic initiatives.

DENTSPLY Sirona navigates revenue decline with strategic restructuring plans

DENTSPLY Sirona's Q2 performance reflects revenue decline and margin contraction, prompting strategic restructuring and focus on customer-centric initiatives. While facing challenges from macroeconomic factors and restructuring impacts, the company aims to leverage opportunities in shareholder returns and market dynamics to drive growth and operational efficiency.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.

DENTSPLY (XRAY) focuses on innovation through active R&D.

Here's Why You Should Invest in DENTSPLY SIRONA (XRAY) Now

Advanced Micro Devices

Anadarko Petroleum

Cadence Design Systems

Chipotle

Coty

MSCI

Total System Services

Xerox

Take a look at the ten stocks that have shown the greatest returns this year to date.

The Top-Performing Stocks Of 2019

Does Dentsply International (XRAY) have what it takes to be a top stock pick for momentum investors? Let's find out.

What Makes Dentsply International (XRAY) a Strong Momentum Stock: Buy Now?

Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock?

Why Is Dentsply (XRAY) Up 3.9% Since Last Earnings Report?

President & CEO of Dentsply Sirona Inc (NASDAQ:XRAY) Donald M Jr. Casey bought 10,000 shares of XRAY on 05/29/2019 at an average price of $53.68 a share.

Dentsply Sirona Inc (XRAY) President & CEO Donald M Jr. Casey Bought $536,800 of Shares

DENTSPLY SIRONA Inc. (XRAY) CEO Donald Casey on Q1 2019 Results - Earnings Call Transcript

DENTSPLY SIRONA (XRAY) Q1 earnings gain from Technology & Equipment unit despite international revenues being down.

DENTSPLY SIRONA (XRAY) Q1 Earnings & Revenues Top Estimates

Dentsply (XRAY) delivered earnings and revenue surprises of 28.95% and 3.17%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Dentsply International (XRAY) Q1 Earnings and Revenues Top Estimates

Higher Consumable revenues, product innovation and focus on R&D likely to aid DENTSPLY SIRONA (XRAY) in Q1 earnings. However, contraction is gross margin might be a dampener.

DENTSPLY SIRONA (XRAY) Q1 Earnings: What's in the Cards?

Merit Medical Systems

XRAY vs. MMSI: Which Stock Is the Better Value Option?

XRAY or MMSI: Which Is the Better Value Stock Right Now?

Investors warmed to the company's turnaround plan following a good set of earnings.

Why Shares in Dentsply Sirona Soared Nearly 19% in March

Strong prospects in emerging markets provide DENTSPLY a competitive edge in the MedTech space.

Here's Why You Should Invest in DENTSPLY Stock Now

Dentsply (XRAY) Up 18.8% Since Last Earnings Report: Can It Continue?

Rowan Cos. Plc

Here are two short trade recommendations for this week.

Stocks This Week: Go Short Rowan And Dentsply Sirona

Dentsply Sirona Inc. is in the midst of a major transition.

BofA Expects Dentsply Sirona's Performance To Improve With New Product Ramp, Cost-Cutting

As of late, it has definitely been a great time to be an investor in DENTSPLY SIRONA.

News for DENTSPLY SIRONA Stock (XRAY)